Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 383, Issue 1

Issues

Growth Factor-Dependent Proliferation and Invasion of Muscle Satellite Cells Require the Cell-Associated Fibrinolytic System

Gabriella Fibbi / Silvia DAlessio / Marco Pucci / Massimiliano Cerletti / Mario Del Rosso
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2002.013

Abstract

The process of muscle regeneration in normal and dystrophic muscle depends on locally produced cytokines and growth factors and requires the activity of the urokinase plasminogen activator/urokinase plasminogen activator receptor/plasminogen activator inhibitor-1 system. In this study we tested the effect of basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF) and transforming growth factorβ (TGFβ) on the fibrinolytic pattern of normal and dystrophic satellite cells, their mitogenic and motogenic activities and the dependence of such activities on the cellassociated fibrinolytic system. We have observed that the urokinase plasminogen activator (uPA) receptor is weakly upregulated by bFGF in normal satellite cells, while it is strongly upregulated by TGFβ, mainly in dystrophic myoblasts. bFGF upregulated uPA in both normal and dystrophic myoblasts grown in primary culture, while a striking downregulation was observed with TGFβ. TGFβ was the only growth factor able to exceptionally upregulate plasminogen activator inhibitor-1 (PAI-1), mainly in dystrophic satellite cells. HGF did not show any activity on the fibrinolytic system. Proliferation and invasion into Matrigel matrices of normal and dystrophic cells occurred regardless of the growth factordependent regulation of the fibrinolytic system. Nevertheless, each growth factor required the efficiency of the constitutive cellassociated fibrinolytic system to operate, as shown by impairment of growth factor activity with antagonists of uPA and of its receptor. Noteworthy, TGFβ induced a dosedependent increase of Matrigel invasion only in dystrophic myoblasts. Since TGFβchallenged dystrophic myoblasts undergo an exceptional upregulation of the receptor and of PAI-1, we propose the possibility that the TGFβinduced fibrinolytic pattern (low urokinase plasminogen activator, high receptor and high PAI-1) may be exploited to promote survival and spreading of transplanted engineered myoblasts in Duchenne muscular dystrophy.

About the article

Published Online: 2005-06-01

Published in Print: 2002-01-23


Citation Information: Biological Chemistry, Volume 383, Issue 1, Pages 127–136, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2002.013.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Timothy J. Koh, Scott C. Bryer, Augustina M. Pucci, and Thomas H. Sisson
American Journal of Physiology-Cell Physiology, 2005, Volume 289, Number 1, Page C217
[2]
Jianming Liu, Praveen B. Gurpur, and Stephen J. Kaufman
Journal of Biological Chemistry, 2008, Volume 283, Number 51, Page 35668
[3]
Mei-Chi Chang, Hsiao-Hua Chang, Po-Shuan Lin, Yu-An Huang, Chiu-Po Chan, Yi-Ling Tsai, Shen-Yang Lee, Po-Yuan Jeng, Han-Yueh Kuo, Sin-Yuet Yeung, and Jiiang-Huei Jeng
Journal of Tissue Engineering and Regenerative Medicine, 2017
[4]
Michelle M. Schiro, Sara E. Stauber, Tami L. Peterson, Chateen Krueger, Steven J. Darnell, Kenneth A. Satyshur, Norman R. Drinkwater, Michael A. Newton, F. Michael Hoffmann, and Dhyan Chandra
PLoS ONE, 2011, Volume 6, Number 9, Page e25021
[5]
Dilek Yıldız Sevgi, Banu Bayraktar, Alper Gündüz, Banu Yılmaz Özgüven, Alper Togay, Emin Bulut, Nuray Uzun, and İlyas Dökmetaş
Wiener klinische Wochenschrift, 2016, Volume 128, Number 1-2, Page 28
[6]
M. P. Krause, J. Moradi, A. A. Nissar, M. C. Riddell, and T. J. Hawke
Diabetes, 2011, Volume 60, Number 7, Page 1964
[7]
Young Min Ju, Anthony Atala, James J. Yoo, and Sang Jin Lee
Acta Biomaterialia, 2014, Volume 10, Number 10, Page 4332
[8]
Ryan M. Francis, Christine L. Romeyn, Adam M. Coughlin, Paul R. Nagelkirk, Christopher J. Womack, and Jeffrey T. Lemmer
European Journal of Applied Physiology, 2014, Volume 114, Number 6, Page 1229
[9]
T. H. Sisson, M.-H. Nguyen, B. Yu, M. L. Novak, R. H. Simon, and T. J. Koh
Blood, 2009, Volume 114, Number 24, Page 5052
[10]
Matthew P Krause, Michael C Riddell, and Thomas J Hawke
Pediatric Diabetes, 2011, Volume 12, Number 4pt1, Page 345
[11]
Jean Francois Lafreniere, Philippe Mills, Jacques Pierre Tremblay, and Elmostafa El Fahime
Transplantation, 2004, Volume 77, Number 11, Page 1741
[12]
K. Brimah, J. Ehrhardt, V. Mouly, G.S. Butler-Browne, T.A. Partridge, and J.E. Morgan
Human Gene Therapy, 2004, Volume 15, Number 11, Page 1109
[13]
Ian B. Copland, Simon Lord-Dufour, Jessica Cuerquis, Daniel L. Coutu, Borhane Annabi, Eugenea Wang, and Jacques Galipeau
Stem Cells, 2009, Volume 27, Number 2, Page 467

Comments (0)

Please log in or register to comment.
Log in